Placeholder

Fee-For-Service: Getting What You Pay For

$30.00

Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at mwalsh@pharmavoice.com.

SKU: 242. Categories: , .

Product Description

VIEW on Wholesale Pricing Models

In an exclusive to PharmaVOICE, Adam J. Fein, Ph.D., Founder and President of Pembroke Consulting Inc., a firm that helps senior executives of wholesale distribution, manufacturing, and B2B technology companies build and sustain market leadership, discusses why pharmaceutical manufacturers must learn how to use fee structures to leverage their influence and encourage true supply-chain partnerships.
Fee-for-service payments should be designed to reward concrete actions that build a company’s brands, lower supply-chain costs, speed new product launches, and take into account any other actions required relevant to a company’s business objectives.
The shift to a fee-for-service pricing model in pharmaceutical wholesaling is slowly but steadily gaining momentum. The wholesale channel will not change overnight, but as evolution occurs the contribution of wholesalers to sales, marketing, customer service, and logistics requirements also can change. According to Adam J. Fein, Ph.D., founder and president of Pembroke Consulting Inc., pharmaceutical manufacturers must learn how to use fee structures to leverage their influence and encourage true supply-chain partnerships. Otherwise, they risk missing an opportunity to think strategically about these new compensation models…

Expert on this Topic
Adam J. Fein, Ph.D., Founder and President,Pembroke Consulting Inc.

FEEDBACK